Chad Campion, MD, a spine surgeon at Baptist Memorial Hospital in Memphis, Tenn., was the first surgeon to used the 7D Flash navigation system in combination with the Firebird spinal fixation system, devicemaker Orthofix said in a Feb. 25 LinkedIn post.

FloSpine's 3D-printed Ti-Largo earned FDA 510(k) clearance, the devicemaker said Feb. 28.

NuVasive's Pulse spine platform surpassed 2,000 commercial cases since it was released in 2021, CEO Chris Barry said in a fourth-quarter earnings call.

Globus Medical and NuVasive both raked in more than $1 billion in 2022 revenue, along with fourth quarter sales increases ahead of their planned merger.

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth quarter financial results, and data on their orthopedic sales.

Spinal implant company Expanding Innovations has received FDA 510(k) clearance for its X-Pac Expandable Lateral Cage System, a non-screw-based implant that addresses the core principles of lateral lumbar interbody fusion. 

NuVasive's Modulus cervical interbody implant was approved by the FDA for use with a bone void filler, the devicemaker said Feb. 21.

Medtronic on Feb. 21 posted $7.7 billion in revenue during the third quarter of fiscal year 2023.

Here are five spine devices that have recently gained FDA clearance that Becker's has reported on since Jan. 17:

Medical technology company Stryker has earned 510(k) FDA clearance for its Q Guidance System with Cranial Guidance Software. 

ZimVie is the current leader in the U.S. spine artificial disc replacement market with respect to its overall revenue and units sold, according to a report from consulting and market research firm iData Research.

Here are eight key developments from spine and orthopedic medtech companies since Nov. 22:

Ulrich Medical's Momentum minimally invasive spine system was used in its first case, the devicemaker said Feb. 14.

Centinel Spine reached the 500th case with prodisc C Vivo and prodisc C SK, the devicemaker said Feb. 14.

The global surgical robot market has hit $3 billion and is expected to grow in the next decade, especially in othopedics and neurosurgery, according to a report from Bain & Company. 

The year kicked off with a splashy merger between spine medtech companies, and another key acquisition is on the horizon.

Globus Medical's shares fell 18 percent following news that it is acquiring NuVasive, valuing the spine devicemaker at $3.1 billion, Seeking Alpha reported Feb. 9.

Elon Musk's brain implant company, Neuralink, is under investigation over allegations it unsafely packaged and transported materials with infectious pathogens at research facilities at the University of California Davis. 

Carlsbad, Calif.-based Spinal Elements named Ron Lloyd as president and CEO. 

Globus Medical is buying spine devicemaker NuVasive, valuing it at $3.1 billion.